Nasopharyngeal carriage of streptococcus pneumoniae in gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings

Pediatric Infectious Disease Journal

Volumn 28, Issue 11, 2009, Pages 990-995

  Cheung, Yin Bun ^a,b   Zaman, Syed M A ^c   Nsekpong, Ekpedeme David ^d   Van Beneden, Chris A ^e   Adegbola, Richard A ^d   Greenwood, Brian ^f   Cutts, Felicity T ^d  

^a SINGAPORE CLINICAL RESEARCH INSTITUTE   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^e NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Antibiotic resistance; Carriage; Conjugate vaccine; Streptococcus pneumoniae

Indexed keywords

COTRIMOXAZOLE; PLACEBO; PNEUMOCOCCUS VACCINE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CARRIER; BACTERIUM ISOLATE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GAMBIA; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; NASOPHARYNX; NONHUMAN; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEROTYPE; SIBLING; STREPTOCOCCUS PNEUMONIAE;

EID: 70350548096     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181a78185     Document Type: Article

References (33)

1. Greenwood B. The epidemiology of pneumococcal infection in children in the developing world. Philos Trans R Soc Lond B Biol Sci. 1999;354:777-785.
2. Scott JA. The preventable burden of pneumococcal disease in the developing world. Vaccine. 2007;25:2398-2405.
3. Black S, Shinefield H, Fireman B, et al. Northern California Kaiser Permanente Vaccine Study Center Group. Efficacy, safety and immunoge-nicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 2000;19:187-195.
4. Hansen J, Black S, Shinefield H, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatr Infect Dis J. 2006;25:779-781.
5. Klugman KP, Madhi SA, Huebner RE, et al. A trial of a 9-valent pneumo-coccal conjugate vaccine in children with and those without HIV infection. N Engl J Med. 2003;349:1341-1348.
6. Cutts FT, Zaman SM, Enwere G, et al. Efficacy of nine-valent pneumo-coccal conjugate vaccine against pneumonia and invasive pneumococcal disease in the Gambia: randomised, doubled-blind, placebo-controlled trial. Lancet. 2005;365:1139-1146. (Pubitemid 40417563)
7. Obaro SK, Adegbola RA, Banya WA, et al. Carriage of pneumococci after pneumococcal vaccination. Lancet. 1996;348:271-272.
8. Mbelle N, Huebner RE, Wasas AD, et al. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis. 1999;180:1171-1176.
9. Dagan R, Givon-Lavi N, Zamir O, et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis. 2002;185:927-936.
10. Givon-Lavi N, Fraser D, Dagan R. Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings. Pediatr Infect Dis J. 2003;22:524-532.
11. Veenhoven RH, Bogaert D, Schilder AG, et al. Nasopharyngeal pneumo-coccal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media. Clin Infect Dis. 2004;39:911-919.
12. Millar EV, O'Brien KL, Watt JP, et al. Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population. Clin Infect Dis. 2006;43:8-15.
13. O'Brien KL, Millar EV, Zell ER, et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmu-nized children in a community-randomized trial. J Infect Dis. 2007;196: 1211-1220.
14. Hill PC, Akisanya A, Sankareh K, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers. Clin Infect Dis. 2006;43: 673-679.
15. Millar EV, Watt JP, Bronsdon MA, et al. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members. Clin Infect Dis. 2008;47:989-996.
16. Dinleyici EC, Yargic ZA. Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the post vaccine era. Expert Rev Vaccines. 2008;7:1367-1394.
17. Dagan R, Givon-Lavi N, Zamir O, et al. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Pediatr Infect Dis J. 2003;22:532-540.
18. Farell DJ, Klugman KP, Pichichero M. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after introduction of the 7-valent pneumococcal vaccine in the United States. Pediatr Infect Dis J. 2007;26:123-128.
19. Park SY, Moore MR, Burden DL, et al. Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children. Pediatr Infect Dis J. 2008;27:335-340.
20. Dagan R, Givon-Lavi N, Leibovitz E, et al. Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in anunvaccinated population. J Infect Dis. 2009; 199:776-785.
21. Hill PC, Cheung YB, Akisanya A, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants-a longitudinal study. Clin Infect Dis. 2008;46:807-814.
22. O'Brien KL, Nohynek H; World Health Organization Pneumococcal Vaccine Trials Carriage Working Group. Report from a WHO working group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J. 2003;22:133-140.
23. Brueggemann AB, Griffiths DT, Meats E, et al. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype-and clone-specific differences in invasive disease potential. J Infect Dis. 2003; 187:1424-1432.
24. Saha SK, Baqui AH, Darmstadt GL, et al. Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implications for treatment policy and vaccine formulation. J Clin Microbiol. 2003;41:5582-5587.
25. Mehta CR, Patel NR. Exact logistic regression: theory and examples. Stat Med. 1995;14:2143-2160.
26. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-130.
27. Käyhty H, Auranen K, Nohynek H, et al. Nasopharyngeal colonization: a target for pneumococcal vaccination. Expert Rev Vaccines. 2006;5:651-667.
28. Abdullahi O, Nyiro J, Lewa P, et al. The descriptive epidemiology of Streptococcus pneumoniae and Haemophilus influenzae nasopharyngeal carriage in children and adults in Kilifi district, Kenya. Pediatr Infect Dis J. 2008;27:59-64.
29. Obaro SK, Adegbola RA, Chang I, et al. Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants. Pediatr Infect Dis J. 2000;19:463-469.
30. Saaka M, Okoko B, Kohberger RC, et al. Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia. Vaccine. 2008;26:3719-3726.
31. Whitney CG, Pilishvili T, Farley MM, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet. 2006;368:1495-1502.
32. Moore MR, Gertz RE, Woodbury RL, et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. Clin Infect Dis. 2008;197:1016-1027.
33. Adegbola RA, Hill PC, Secka O, et al. Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003. Trop Med Int Health. 2006;11:1128-1135.